Who
Edward J. Rapp
Director
Company insider
Files Form 4 as: Director, Xos; Director, AbbVie; Group President, Caterpillar.
In numbers
- Trades disclosed
- 257
- Buys
- 8
- Sells
- 12
- Bought
- $1.9M
- Sold
- $22.0M
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 31 Jan 2006
- Last trade
- 10 Oct 2026
- Last filed
- 13 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Oct 2026filed 13 Oct 2026 | XOS XosAuto Parts & Dealers | SEC FORM 4 Code A | —1,814 at $0.00 | filing |
| 30 Sep 2026filed 2 Oct 2026 | ABBV AbbVieoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $34K129 at $261.59 | filing |
| 10 Jul 2026filed 14 Jul 2026 | XOS XosAuto Parts & Dealers | SEC FORM 4 Code A | —2,670 at $0.00 | filing |
| 10 Jul 2026filed 14 Jul 2026 | XOS XosAuto Parts & Dealers | SEC FORM 4 Code A | —60,584 at $0.00 | filing |
| 10 Jul 2026filed 14 Jul 2026 | XOS XosAuto Parts & Dealers | SEC FORM 4 Code A | —2,670 at $0.00 | filing |
| 10 Jul 2026filed 14 Jul 2026 | XOS XosAuto Parts & Dealers | SEC FORM 4 Code A | —60,584 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | ABBV AbbVieoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $34K134 at $251.64 | filing |
| 30 Jun 2026filed 2 Jul 2026 | ABBV AbbVieoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $34K134 at $251.64 | filing |
| 8 May 2026filed 12 May 2026 | ABBV AbbViePharmaceuticals | SEC FORM 4 Code A | —1,118 at $0.00 | filing |
| 8 May 2026filed 12 May 2026 | ABBV AbbViePharmaceuticals | SEC FORM 4 Code A | —1,118 at $0.00 | filing |
| 10 Apr 2026filed 14 Apr 2026 | XOS XosAuto Parts & Dealers | SEC FORM 4 Code A | —5,182 at $0.00 | filing |
| 10 Apr 2026filed 14 Apr 2026 | XOS XosAuto Parts & Dealers | SEC FORM 4 Code A | —5,182 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | ABBV AbbVieoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $34K155 at $217.49 | filing |
| 31 Mar 2026filed 2 Apr 2026 | ABBV AbbVieoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $34K155 at $217.49 | filing |
| 10 Jan 2026filed 13 Jan 2026 | XOS XosAuto Parts & Dealers | SEC FORM 4 Code A | —2,401 at $0.00 | filing |
| 10 Jan 2026filed 13 Jan 2026 | XOS XosAuto Parts & Dealers | SEC FORM 4 Code A | —2,401 at $0.00 | filing |
| 31 Dec 2025filed 5 Jan 2026 | ABBV AbbVieoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $34K147 at $228.49 | filing |
| 31 Dec 2025filed 5 Jan 2026 | ABBV AbbVieoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $34K147 at $228.49 | filing |
| 10 Oct 2025filed 14 Oct 2025 | XOS XosAuto Parts & Dealers | SEC FORM 4 Code A | —1,883 at $0.00 | filing |
| 30 Sep 2025filed 2 Oct 2025 | ABBV AbbVieoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | $34K145 at $231.54 | filing |
News
Caterpillar (NYSE:CAT) Stock Falls 5% – Time to Sell?CAT · dailypolitical.com · 23 Oct 2026Caterpillar Inc. $CAT Stock: Vest Financial LLC Cuts HoldingsCAT · dailypolitical.com · 22 Oct 2026AbbVie (NYSE:ABBV) & TScan Therapeutics (NASDAQ:TCRX) Financial ComparisonABBV · tickerreport.com · 22 Oct 2026AbbVie reaches agreement with the pan-Canadian Pharmaceutical Alliance (pCPA) for ELAHERE® in Platinum-Resistant Ovarian CancerABBV · cantechletter.com · 21 Oct 2026Harfst & Associates Inc. Purchases 38,662 Shares of Caterpillar Inc. $CATCAT · dailypolitical.com · 21 Oct 2026AbbVie vs. Bristol Myers: Is AbbVie's Valuation Premium Worth Paying?ABBV · insidermonkey.com · 19 Oct 2026
0 headlines in the last 90 days name Edward J. Rapp; 6 articles from the last 14 days about the 3 companies they traded most, at most three about any one of them.